SCHEMBL126027

SCHEMBL126027

Fc1ccc(C2CCCCC2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 1/20 0.45
HTT P42858 2/20 0.44
LMNA P02545 1/20 0.44
HDAC1 Q13547 1/20 0.44
HDAC8 Q9BY41 1/20 0.44
HDAC6 Q9UBN7 1/20 0.44
KMT2A Q03164 3/20 0.43
KDM1A O60341 2/20 0.43
TDP1 Q9NUW8 2/20 0.43
NOTUM Q6P988 2/20 0.43
HSP90AA1 P07900 1/20 0.43
GAA P10253 1/20 0.43
MAPT P10636 1/20 0.43
CYP11B2 P19099 1/20 0.42
HAO1 Q9UJM8 1/20 0.42
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
ESR2 Q92731 1/20 0.41
DHODH Q02127 1/20 0.40
MEN1 O00255 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18805040 1.00 ATM (0.45) ATMHTTLMNAHDAC1HDAC8
SCHEMBL779666 0.97 ATM (0.46) ATMHTTLMNAHDAC1HDAC8
Benzene SCHEMBL26615260 0.95 SLC18A3 (0.46) ATMHTTLMNAHDAC1HDAC8
SCHEMBL15906653 0.93 NOTUM (0.47) ATMHTTLMNAKMT2ATDP1
SCHEMBL353495 0.92 ESR2 (0.47) ATMHDAC1HDAC8HDAC6KDM1A
Bicarbonate SCHEMBL9321721 0.89 HAO1 (0.51) ATMHTTHDAC1HDAC8HDAC6
SCHEMBL1066184 0.87 KDM1A (0.48) ATMKDM1ATDP1ESR2
SCHEMBL18161913 0.87 KDM1A (0.48) ATMKDM1ATDP1ESR2
SCHEMBL18459126 0.87 LMNA (0.40) ATMHTTLMNAHDAC1HDAC8
SCHEMBL6275125 0.87 HDAC8 (0.52) HTTLMNAHDAC1HDAC8HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1741 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4712192-A1 ELECTROLYTE SOLUTION FOR NONAQUEOUS ELECTROLYTE SECONDARY BATTERY, AND NONAQUEOUS ELECTROLYTE SECONDARY BATTERY CONTAINING SAME Central Glass Co., Ltd. (JP) 2026-03-18 EP claimed
WO-2025070770-A1 COMPOUND HAVING OXAZOLIDINE STRUCTURE, NONAQUEOUS ELECTROLYTE CONTAINING SAID COMPOUND, AND NONAQUEOUS ELECTROLYTE BATTERY CONTAINING SAID NONAQUEOUS ELECTROLYTE セントラル硝子株式会社 2025-04-03 WO claimed
WO-2025070769-A1 NONAQUEOUS ELECTROLYTE SOLUTION AND NONAQUEOUS ELECTROLYTE BATTERY USING SAME セントラル硝子株式会社 2025-04-03 WO claimed
US-20250105353-A1 Electrolyte Solution for Nonaqueous Electrolyte Batteries, and Nonaqueous Electrolyte Battery Using Same CENTRAL GLASS COOMPANY, LIMITED (JP) 2025-03-27 US claimed
US-12199241-B2 Electrolyte solution for nonaqueous electrolyte batteries, and nonaqueous electrolyte battery using same CENTRAL GLASS COMPANY, LIMITED (JP) 2025-01-14 US claimed
WO-2024253162-A1 ELECTROLYTE SOLUTION FOR NONAQUEOUS ELECTROLYTE SECONDARY BATTERY, AND NONAQUEOUS ELECTROLYTE SECONDARY BATTERY CONTAINING SAME セントラル硝子株式会社 2024-12-12 WO claimed
US-20240339730-A1 ELECTROCHEMICAL DEVICE NINGDE AMPEREX TECHNOLOGY LIMITED (CN) 2024-10-10 US claimed
US-20240313263-A1 Lithium-Ion Battery SHENZHEN CAPCHEM TECHNOLOGY CO., LTD (CN) 2024-09-19 US claimed
EP-4411963-A2 ELECTROCHEMICAL DEVICE Ningde Amperex Technology Ltd. (CN) 2024-08-07 EP claimed
US-12057602-B2 Electrochemical device NINGDE AMPEREX TECHNOLOGY LIMITED (CN) 2024-08-06 US claimed
US-20070054185-A1 Performance such as cycle characteristics, electric capacity, and storage characteristics UBE INDUSTRIES, LTD. (JP) 2007-03-08 US claimed
US-20070048607-A1 Nonaqueous-electrolyte secondary battery MITSUBISHI CHEMICAL CORPORATION (JP) 2007-03-01 US claimed
CN-1906794-A Nonaqueous electrolyte solution and lithium secondary battery UBE INDUSTRIES (JP) 2007-01-31 CN claimed
CN-1864299-A Nonaqueous electrolyte solution and lithium secondary battery using same UBE INDUSTRIES (JP) 2006-11-15 CN claimed
EP-1705736-A1 NONAQUEOUS ELECTROLYTE SECONDARY BATTERY Mitsubishi Chemical Corporation (JP) 2006-09-27 EP claimed
EP-1691441-A1 NONAQUEOUS ELECTROLYTE SOLUTION AND LITHIUM SECONDARY BATTERY Ube Industries, Ltd. (JP) 2006-08-16 EP claimed
WO-2006083924-A1 1-ACYLAMINO-2-HYDROXY-3-AMINO-W-ARYLALKANES AS RENIN INHIBITORS VITAE PHARMACEUTICALS, INC. (US) 2006-08-10 WO claimed
US-20060177742-A1 Nonaqueous electrolytic solution for lithium secondary battery and lithium secondary battery using the same MU IONIC SOLUTIONS CORPORATION (JP) 2006-08-10 US claimed
EP-1672729-A1 NONAQUEOUS ELECTROLYTE SOLUTION AND LITHIUM SECONDARY BATTERY USING SAME Ube Industries, Ltd. (JP) 2006-06-21 EP claimed
EP-1650826-A1 NONAQUEOUS ELECTROLYTIC SOLUTION FOR LITHIUM SECONDARY BATTERY AND LITHIUM SECONDARY BATTERY USING SAME Ube Industries, Ltd. (JP) 2006-04-26 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240313263-A1 Lithium-Ion Battery MLX, LBR, BCL9L ATM 3322/4885HTT 4719/4885LMNA 727/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.